Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Kyverna flagged new one-year results from its KYSA-8 registrational trial of miv-cel in stiff person syndrome, to be presented at MSToronto2026 on Oct. 21, 2026. Updated Phase 1 investigator-initiated progressive multiple sclerosis findings will be presented Oct. 23, 2026. Management said it is working to complete a BL
Kyverna reported positive one-year durability data for miv-cel in stiff person syndrome from its KYSA-8 registrational trial. Key trial endpoints were previously presented at AAN 2026; the full one-year dataset will be presented at MS Toronto on Oct. 21-23, 2026. Results showed sustained clinical benefit through one ye